Flunitrazepam is a powerful hypnotic drug that is a benzodiazepine derivative. It has powerful hypnotic, sedative, anxiolytic, and skeletal muscle relaxant properties. The drug is sometimes used as a date rape drug.

Rohypnol® is a trade name for flunitrazepam, a CNS depressant that belongs to a class of drugs known as benzodiazepines. Flunitrazepam is also marketed as generic preparations and other trade name products outside of the United States. Like other benzodiazepines, Rohypnol® produces sedative-hypnotic, anti-anxiety, and muscle relaxant effects.

Rohypnol is a benzodiazepine drug that can cause amnesia, sedation, and muscle relaxation. It is often used illegally as a date-rape drug or to enhance the effects of other drugs, but it is not available legally in the U.S.

Rohypnol, a trade name for the drug flunitrazepam, is a central nervous system depressant. The drug is legally manufactured and available outside the United States but is neither manufactured nor approved for sale within the United States.

Flunitrazepam is a benzodiazepine drug known for its sedative, hypnotic, and anxiolytic (antianxiety) properties and for its illicit use, most notably as a so-called date rape drug.

Synopsis: Flunitrazepam1 is a benzodiazepine derivative whose hypnotic effect predominates over the sedative, anxiolytic, muscle-relaxing and anticonvulsan.

Flunitrazepam (FNZ) is a sedative–hypnotic benzodiazepine with important therapeutic usefulness and significant abuse liability. Its capability to induce anterograde amnesia favors FNZ use as a “date-rape drug” administered often at a bar or party (“club drug”) by adding it unknowingly to the drinks of victims who will have limited ...

Flunitrazepam is a benzodiazepine compound best known for its use as a date rape drug. Here's what you need to know to stay safe.

Flunitrazepam (FNZ) (Figure 1) is a sedative–hypnotic benzodiazepine that is used for short-term treatment of insomnia, for premedication in surgical procedures, and for inducing anesthesia (Jenkins et al., 2008; Smith, 1994).